Capasso Planning Partners LLC Abbott Laboratories Transaction History

Capasso Planning Partners LLC

$236 Million
Q4 2024

A detailed history of Capasso Planning Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capasso Planning Partners LLC holds 3,322 shares of ABT stock, worth $432,457. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,322

Previous 4,174 20.41%

Holding current value

$432,457

Previous $475,000 21.05%

% of portfolio

0.16%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$111.93 - $119.39 $95,364 - $101,720	-852 Reduced 20.41%	3,322 $375,000
Q3 2024 Dec 02, 2024	BUY	$100.07 - $118.13 $800 - $945	8 Added 0.19%	4,174 $475,000
Q2 2024 Dec 02, 2024	SELL	$100.73 - $112.44 $19,138 - $21,363	-190 Reduced 4.36%	4,166 $432,000
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $8,433 - $9,313	77 Added 1.8%	4,356 $495,000
Q4 2023 Jan 26, 2024	BUY	$90.19 - $110.4 $450 - $552	5 Added 0.12%	4,279 $470,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $8,693 - $10,430	-91 Reduced 2.08%	4,274 $413,000
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $41,924 - $46,712	416 Added 10.53%	4,365 $475,000
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $3,293 - $3,876	-34 Reduced 0.85%	3,949 $399,000
Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $3,802 - $4,460	-40 Reduced 0.99%	3,983 $0
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $7,257 - $8,402	75 Added 1.9%	4,023 $389,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $6,430 - $7,772	63 Added 1.62%	3,948 $429,000
Q4 2021 Feb 17, 2022	BUY	$115.53 - $141.46 $448,834 - $549,572	3,885 New	3,885 $547,000

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capasso Planning Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capasso Planning Partners LLC with notifications on news.

Account

Capasso Planning Partners LLC Abbott Laboratories Transaction History